Skip to main content
ArticlePDF AVAILABLE

Dapagliflozin in patients with COVID-19: truth or dare

The Lancet Diabetes and Endocrinology
DOI: 10.1016/S2213-8587(21)00206-0
3Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Cite

CITATION STYLE

APA

Rossello, X., & Caimari, F. (2021, September 1). Dapagliflozin in patients with COVID-19: truth or dare. The Lancet Diabetes and Endocrinology. Lancet Publishing Group. https://doi.org/10.1016/S2213-8587(21)00206-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free